Karen Eggleston joined the Walter H. Shorenstein Asia-Pacific Research Center in the summer of 2007 to lead the center's Asia Health Policy Program. She is also a Fellow with the Center for Innovation in Global Health (CIGH) at Stanford University School of Medicine, a fellow at Stanford's Center for Health Policy/Primary Care and Outcomes Research (CHP/PCOR), and a Faculty Research Fellow of the National Bureau of Economic Research (NBER). Her research focuses on comparative healthcare systems and health reform in Asia, especially China; government and market roles in the health sector; payment incentives; healthcare productivity; and the economics of the demographic transition. Eggleston teaches through Stanford's East Asian studies and International Policy Studies programs and is also affiliated with Stanford's public policy program.
Eggleston earned her PhD in public policy from Harvard University in 1999. She has MA degrees in economics and Asian studies from the University of Hawaii (August 1995 and May 1992, respectively), and earned a BA in Asian studies summa cum laude (valedictorian) from Dartmouth College in 1988. Eggleston studied in China for two years and was a Fulbright scholar in Korea. She was a consultant to the World Bank on their project on health service delivery in rural China in 2004, to China's Ministry of Finance and the Asian Development Bank from 2010 to 2011 for an evaluation of China's health reforms, and to the World Bank/WHO/Government of China 2015 report on China's health service delivery system. She was a member of the Strategic Technical Advisory Committee for the Asia Pacific Observatory on Health Systems and Policies.
Senior Fellow, Freeman Spogli Institute for International Studies
Honors & Awards
“Adoption of New Technologies in Japan” with Yong S. Lee, FSI Japan Fund (2018-19)
Faculty research award, ‘Value for Money’ in Diabetes Control in South and Southeast Asia", Shorenstein APARC (March 1, 2017-February 28, 2018)
Faculty research award, “Innovation for Healthy Aging: Public and Private Roles in East Asia, Shorenstein APARC (February 1, 2018-January 31, 2019)
Center for Clinical & Translational Research & Education, Spectrum Pilot Grant, Stanford University School of Medicine (January-December 2017)
Economic Dimensions of Personalized and Precision Medicine, National Bureau of Economic Research, USC Schaeffer Center for Health Policy & Economics
Controlling Chronic Disease in China, FSI International Policy Implementation Lab, Stanford University (June 2016-May 2018)
Faculty Fellowship for research focused on China’s health policy reforms, Stanford Center at Peking University (June 2016-June 2017)
“Adapting the Future Elderly Model to Japan,” with Jay Bhattacharya, Stanford University Center for Demography and Economics of Health and Aging (October 2014-June 2015)
Invited speaker on panel on demographics, Federal Reserve Bank Jackson Hole Symposium, Jackson, Wyoming (August 22-23, 2014)
Invited keynote speaker, "The Demographic Challenge for Health and Social Protection", 13th Conference of GIZ's SN Health and Social Protection in Asia and Eastern Europe, Hanoi, Viet Nam (November 13, 2013)
CAUSES: Causes of Asian American mortality Understood by Socio-Economic Status, National Institutes of Health/National Institute on Minority Health and Health Disparities (NIMHD) (April 2012-March 2017)
National Institutes of Health/National Institute on Aging, Stanford University Center for Demography and Economics of Health and Aging (CDEHA) (January-June 2011)
National Institutes of Health/National Institute on Aging, Stanford University Center for Demography and Economics of Health and Aging (CDEHA) (June 2008-Jun 2010)
Hewlett Faculty Grant for participation in “Strengthening Public Health Systems in the Pacific Rim”, Freeman Spogli Institute for International Studies (June 2008)
Invited keynote speaker, Western Economics Association International conference in Beijing, PRC (January 14, 2007)
World Bank Beijing Office Grant, World Bank Beijing Office (April-December, 2005)
Grant, The Robert Wood Johnson Foundation’s Health Care Financing and Organization Initiative (June 2004 -November 2005)
Research Grant, Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services (July 2003-June 2004)
Grant, The Robert Wood Johnson Foundation’s Health Care Financing and Organization Initiative (December 2002-May 2004)
Fellowship, Economics of Aging, National Bureau of Economic Research (NBER) (1998)
Fellowship, East-West Center, Honolulu/Manoa, Hawaii (1990-1992)
Fulbright Scholarship, Yonsei University, Seoul, Korea (1989-1990)
Reynolds Scholarship, Johns Hopkins-Nanjing University Center for Chinese and American Studies (1988-1989)
Boards, Advisory Committees, Professional Organizations
Faculty Research Fellow, National Bureau of Economic Research (2012 - Present)
Strategic Technical Advisory Committee, Asia Pacific Observatory on Health Systems and Policies (2011 - 2017)
Advisory Board Member, Aging and Health Research Center, Xi'an Jiaotong University, Xi'an, China (2012 - Present)
Editorial Board, Journal of the Economics of Aging (2012 - Present)
Academic Program Coordinator, Harvard University Kennedy School of Government Health Care Delivery Policy Program (2001 - 2008)
Research Associate, Harvard University Kennedy School of Government (1999 - 2006)
Global Fellow, International Institute, University of California, Los Angeles (2006 - 2007)
Center for East Asian Studies
Ph.D., Harvard University, Public Policy (1999)
M.A., University of Hawaii, Economics (1995)
M.A., University of Hawaii, Asian Studies (1992)
B.A., Dartmouth College, Asian Studies (Valedictorian) (1988)
Current Research and Scholarly Interests
Health reform in China; comparative healthcare systems in Asia; government and market roles in the health sector; payment incentives; healthcare productivity; and economic implications of demographic change.
The Impact of Health Insurance on Survival: Evidence from NCMS in Rural China, China CDC and Stanford (Asia Health Policy Program and School of Medicine colleagues)
The Net Value of Health Screening and Incentives for Management of Diabetes and Hypertension in Japan, 2005-2012, Stanford University and University of Tokyo collaborators
Trends in Disability in a Super-Aging Society: Adapting the Future Elderly Model to Japan, Stanford University and University of Tokyo collaborators
Disparities in Health and Healthcare in Myanmar
Diabetes Prevalence and Risk Factors among Vietnamese Adults
The Economics of Population Aging in China and India, Stanford and Harvard colleagues
Managing Chronic Disease in Rural China: Will lowering drug copayments enhance adherence and improve outcomes?, Stanford Asia Health Policy Program and Shandong Province Department of Health
The Educational Gradient in Health: Evidence from China, Stanford University and China Academy of Social Science collaborators
- Health and Healthcare Systems in East Asia
EASTASN 117, EASTASN 217 (Win)
- Independent Studies (4)
- Prior Year Courses
- Enhancing financial protection under China's social health insurance to achieve universal health coverage. BMJ (Clinical research ed.) 2019; 365: l2378
Economic Impact of Diabetes in South Asia: the Magnitude of the Problem.
Current diabetes reports
2019; 19 (6): 34
PURPOSE OF REVIEW: To critically assess and identify gaps in the current literature on the economic impact of diabetes in South Asia.RECENT FINDINGS: The total annual (direct medical and non-medical and indirect) costs for diabetes care in South Asia range from $483-$2637 per patient, and on an average 5.8% of patients with diabetes suffer catastrophic spending i.e. when households reduce basic expenditure by 40% to cope with healthcare costs. The mean direct costs per patient are positively associated with a country's gross domestic product (GDP) per capita, although there is wide heterogeneity across South Asian countries. With an estimated 84 million people suffering from diabetes in South Asia, diabetes imposes a substantial economic burden on individuals, families, and society. Since the disease burden increasingly occurs in the most productive midlife period, it adversely affects workforce productivity and macroeconomic development. Diabetes-related complications lead to markedly higher treatment costs, causing catastrophic medical spending for many households, thus underscoring the importance of preventing diabetes-related complications.
View details for DOI 10.1007/s11892-019-1146-1
View details for PubMedID 31098775
- Financing longevity: The economics of pensions, health, and long-term care: Introduction to the special issue JOURNAL OF THE ECONOMICS OF AGEING 2019; 13: 1–6
Direct medical cost of diabetes in rural China using electronic insurance claims data and diabetes management data
JOURNAL OF DIABETES INVESTIGATION
2019; 10 (2): 531–38
To evaluate the annual direct medical cost attributable to type 2 diabetes mellitus according to socioeconomic factors, medical conditions and complications categories.We created uniquely detailed data from merging datasets of the local diabetes management system and the social security system in Tongxiang, China. We calculated the type 2 diabetes mellitus-related total cost and out-of-pocket cost for inpatient admissions and outpatient visits, and compared the cost for patients with or without complications by different healthcare items.A total of 16,675 patients were eligible for analysis. The type 2 diabetes mellitus-related cost accounted for 40.6% of the overall cost. The cost per patient was estimated to be a median of 1,067 Chinese Yuan, 7,114 Chinese Yuan and 969 Chinese Yuan for inpatient and outpatient cost, respectively. The median total cost for hospital-based care was 3.69-fold higher than that for primary care. The median cost of patients with complications was 3.46-fold higher than that of those without complications. The median cost for a patient with only macrovascular, only microvascular or both macrovascular and microvascular complications were 3.13-, 3.79- and 10.95-fold higher than that of patients without complications. Pharmaceutical expenditure accounted for 51.8 and 79.7% of the total cost for patients with or without complications, respectively.Although the type 2 diabetes mellitus-related cost per patient was relatively low, it accounted for a great proportion of the overall cost. Complications obviously aggravated the economic burden of type 2 diabetes mellitus. Proper management and the prevention of diabetes and its complications are urgently required to curtail the economic burden.
View details for PubMedID 29993198
- How do type 2 diabetes mellitus (T2DM)-related complications and socioeconomic factors impact direct medical costs? A cross-sectional study in rural Southeast China BMJ OPEN 2018; 8 (11)
The impact of social pensions on intergenerational relationships: Comparative evidence from China
JOURNAL OF THE ECONOMICS OF AGEING
2018; 12: 225–35
China launched a new rural pension scheme (hereafter NRPS) for rural residents in 2009, now covering almost all counties with over 400 million people enrolled. This implementation of the largest social pension program in the world offers a unique setting for studying the economics of intergenerational relationships during development, given the rapidity of China's population aging, traditions of filial piety and co-residence, decreasing number of children, and dearth of formal social security, at a relatively low income level. We draw on rich household surveys from two provinces at distinct development stages - impoverished Guizhou and relatively well-off Shandong - to better understand heterogeneity in the impact of pension benefits. Employing a fuzzy regression discontinuity design, we find that around the pension eligibility age cut-off, the NRPS significantly reduces intergenerational co-residence, especially between elderly parents and their adults sons; promotes pensioners' healthcare service consumption; and weakens (but does not supplant) non-pecuniary and pecuniary transfers across three generations. These effects are much larger in less developed Guizhou province.
View details for PubMedID 30534523
View details for PubMedCentralID PMC6286058
How do type 2 diabetes mellitus (T2DM)-related complications and socioeconomic factors impact direct medical costs? A cross-sectional study in rural Southeast China.
2018; 8 (11): e020647
OBJECTIVE: To evaluate type 2 diabetes mellitus (T2DM)-related direct medical costs by complication type and complication number, and to assess the impacts of complications as well as socioeconomic factors on direct medical costs.DESIGN: A cross-sectional study using data from the region's diabetes management system, social security system and death registry system, 2015.SETTING: Tongxiang, China.PARTICIPANTS: Individuals diagnosed with T2DM in the local diabetes management system, and who had 2015 insurance claims in the social security system. Patients younger than 35 years and patients whose insurance type changed in the year 2015 were excluded.MAIN OUTCOME MEASURES: The mean of direct medical costs by complication type and number, and the percentage increase of direct medical costs relative to a reference group, considering complications and socioeconomic factors.RESULTS: A total of 19015 eligible individuals were identified. The total cost of patients with one complication was US$1399 at mean, compared with US$248 for patients without complications. The mean total cost for patients with 2 and 3+ complications was US$1705 and US$2994, respectively. After adjustment for socioeconomic confounders, patients with one complication had, respectively, 83.55% and 38.46% greater total costs for inpatient and outpatient services than did patients without complications. The presence of multiple complications was associated with a significant 44.55% adjusted increase in total outpatient costs, when compared with one complication. Acute complications, diabetic foot, stroke, ischaemic heart disease and diabetic nephropathy were the highest cost complications. Gender, age, education level, insurance type, T2DM duration and mortality were significantly associated with increased expenditures of T2DM.CONCLUSIONS: Complications significantly aggravated expenditures on T2DM. Specific kinds of complications and the presence of multiple complications are correlated with much higher expenditures. Proper management and the prevention of related complications are urgently needed to reduce the growing economic burden of diabetes.
View details for PubMedID 30389755
- The Impact of Rural Pensions in China on Labor Migration WORLD BANK ECONOMIC REVIEW 2018; 32 (1): 64–84
- INNOVATION AND SHORTAGE: THE YIN AND YANG OF THE HEALTH SECTOR ACTA OECONOMICA 2018; 68: 99–114
Avoidable Hospital Admissions From Diabetes Complications In Japan, Singapore, Hong Kong, And Communities Outside Beijing
2017; 36 (11): 1896–1903
Improving the quality of primary care may reduce avoidable hospital admissions. Avoidable admissions for conditions such as diabetes are used as a quality metric in the Health Care Quality Indicators of the Organization for Economic Cooperation and Development (OECD). Using the OECD indicators, we compared avoidable admission rates and spending for diabetes-related complications in Japan, Singapore, Hong Kong, and rural and peri-urban Beijing, China, in the period 2008-14. We found that spending on diabetes-related avoidable hospital admissions was substantial and increased from 2006 to 2014. Annual medical expenditures for people with an avoidable admission were six to twenty times those for people without an avoidable admission. In all of our study sites, when we controlled for severity, we found that people with more outpatient visits in a given year were less likely to experience an avoidable admission in the following year, which implies that primary care management of diabetes has the potential to improve quality and achieve cost savings. Effective policies to reduce avoidable admissions merit investigation.
View details for PubMedID 29137504
- Village senior centres and the living arrangements of older people in rural China: considerations of health, land, migration and intergenerational support AGEING & SOCIETY 2017; 37 (10): 2044–73
Mortality In Rural China Declined As Health Insurance Coverage Increased, But No Evidence The Two Are Linked
2017; 36 (9): 1672–78
Health insurance holds the promise of improving population health and survival and protecting people from catastrophic health spending. Yet evidence from lower- and middle-income countries on the impact of health insurance is limited. We investigated whether insurance expansion reduced adult mortality in rural China, taking advantage of differences across Chinese counties in the timing of the introduction of the New Cooperative Medical Scheme (NCMS). We assembled and analyzed newly collected data on NCMS implementation, linked to data from the Chinese Center for Disease Control and Prevention on cause-specific, age-standardized death rates and variables specific to county-year combinations for seventy-two counties in the period 2004-12. While mortality rates declined among rural residents during this period, we found little evidence that the expansion of health insurance through the NCMS contributed to this decline. However, our relatively large standard errors leave open the possibility that the NCMS had effects on mortality that we could not detect. Moreover, mortality benefits might arise only after many years of accumulated coverage.
View details for PubMedID 28874497
The Educational Gradient in Health in China
2017; 230: 289–322
It has been well established that better educated individuals enjoy better health and longevity. In theory, the educational gradients in health could be flattening if diminishing returns to improved average education levels and the influence of earlier population health interventions outweigh the gradient-steepening effects of new medical and health technologies. This paper documents how the gradients are evolving in China, a rapidly developing country, about which little is known on this topic. Based on recent mortality data and nationally representative health surveys, we find large and, in some cases, steepening educational gradients. We also find that the gradients vary by cohort, gender and region. Further, we find that the gradients can only partially be accounted for by economic factors. These patterns highlight the double disadvantage of those with low education, and suggest the importance of policy interventions that foster both aspects of human capital for them.
View details for PubMedID 29056815
View details for PubMedCentralID PMC5650237
Patient Copayments, Provider Incentives, and Income Effects: Theory and Evidence From the Essential Medications List Under China's 2009 Healthcare Reform
WORLD MEDICAL & HEALTH POLICY
2017; 9 (1): 24–44
Expanding access through insurance expansion can increase healthcare utilization through moral hazard. Reforming provider incentives to introduce more supply-side cost sharing is increasingly viewed as crucial for affordable, sustainable access. Using both difference-in-differences and segmented regression analyses on a panel of 1,466 hypertensive and diabetic patients, we empirically examine Shandong province's initial implementation of China's 2009 Essential Medications List policy. The policy reduced drug sale markups to providers but also increased drug coverage benefits for patients. We find that providers appeared to compensate for lost drug revenues by increasing office visits, for which no fee reduction occurred. At the same time, physician agency (yielding to patient demand for pharmaceuticals) may have tempered provider incentives to reduce drug expenditures at the visit level. Taken together, the policy may have increased total spending or total out-of-pocket expenditures. Mandating payment reductions in a service that comprises a large portion of provider income may have unintended consequences.
View details for PubMedID 29075552
Forecasting Trends in Disability in a Super-Aging Society: Adapting the Future Elderly Model to Japan.
Journal of the economics of ageing
2016; 8: 42-51
Japan has experienced pronounced population aging, and now has the highest proportion of elderly adults in the world. Yet few projections of Japan's future demography go beyond estimating population by age and sex to forecast the complex evolution of the health and functioning of the future elderly. This study estimates a new state-transition microsimulation model - the Japanese Future Elderly Model (FEM) - for Japan. We use the model to forecast disability and health for Japan's future elderly. Our simulation suggests that by 2040, over 27 percent of Japan's elderly will exhibit 3 or more limitations in IADLs and social functioning; almost one in 4 will experience difficulties with 3 or more ADLs; and approximately one in 5 will suffer limitations in cognitive or intellectual functioning. Since the majority of the increase in disability arises from the aging of the Japanese population, prevention efforts that reduce age-specific morbidity can help reduce the burden of disability but may have only a limited impact on reducing the overall prevalence of disability among Japanese elderly. While both age and morbidity contribute to a predicted increase in disability burden among elderly Japanese in the future, our simulation results suggest that the impact of population aging exceeds the effect of age-specific morbidity on increasing disability in Japan's future.
View details for DOI 10.1016/j.jeoa.2016.06.001
View details for PubMedID 28580275
Mortality outcomes for Chinese and Japanese immigrants in the USA and countries of origin (Hong Kong, Japan): a comparative analysis using national mortality records from 2003 to 2011.
2016; 6 (10)
With immigration and minority populations rapidly growing in the USA, it is critical to assess how these populations fare after immigration, and in subsequent generations. Our aim is to compare death rates and cause of death across foreign-born, US-born and country of origin Chinese and Japanese populations.We analysed all-cause and cause-specific age-standardised mortality rates and trends using 2003-2011 US death record data for Chinese and Japanese decedents aged 25 or older by nativity status and sex, and used the WHO Mortality Database for Hong Kong and Japan decedents in the same years. Characteristics such as age at death, absolute number of deaths by cause and educational attainment were also reported.We examined a total of 10 458 849 deaths. All-cause mortality was highest in Hong Kong and Japan, intermediate for foreign-born, and lowest for US-born decedents. Improved mortality outcomes and higher educational attainment among foreign-born were observed compared with developed Asia counterparts. Lower rates in US-born decedents were due to decreased cancer and communicable disease mortality rates in the US heart disease mortality was either similar or slightly higher among Chinese-Americans and Japanese-Americans compared with those in developed Asia counterparts.Mortality advantages in the USA were largely due to improvements in cancer and communicable disease mortality outcomes. Mortality advantages and higher educational attainments for foreign-born populations compared with developed Asia counterparts may suggest selective migration. Findings add to our limited understanding of the racial and environmental contributions to immigrant health disparities.
View details for DOI 10.1136/bmjopen-2016-012201
View details for PubMedID 27793837
View details for PubMedCentralID PMC5093623
Prevalence and determinants of diabetes and prediabetes among Vietnamese adults.
Diabetes research and clinical practice
2016; 113: 116-124
We estimated the prevalence of diabetes and prediabetes among Vietnamese adults, and quantitatively evaluated association with known risk factors.Subjects were 5602 men and 10,680 women in North Vietnam aged 30-69 years participating in community diabetes screening programs during 2011-2013. We calculated standardized prevalence rates and demographic projections for 2035, and used multinomial regression analysis to examine the associations of multiple risk factors with diabetes and prediabetes.The age-, sex- and area of residence-standardized prevalence of diabetes was 6.0% and of prediabetes was 13.5%, with higher prevalence among men than women. Population aging is projected to raise the prevalence of diabetes to 7.0% and of prediabetes to 15.7% by 2035. Older age, obesity, large waist-to-hip ratio and hypertension were each associated with higher prevalence of diabetes, whereas the opposite direction of association was observed for underweight and minority ethnicity. In addition, diabetes was positively associated with family history of diabetes in women, but inversely related to physically heavy work among men.One in 17 and one in 7 adults had diabetes and prediabetes, respectively, in Vietnam. Urbanization, population aging, increased adiposity, hypertension and sedentary work are associated with the increasing prevalence of diabetes.
View details for DOI 10.1016/j.diabres.2015.12.009
View details for PubMedID 26795973
The weaker sex? Vulnerable men and women's resilience to socio-economic disadvantage.
SSM - population health
2016; 2: 512–24
Sex differences in mortality vary over time and place as a function of social, health, and medical circumstances. The magnitude of these variations, and their response to large socioeconomic changes, suggest that biological differences cannot fully account for sex differences in survival. Drawing on a wide swath of mortality data across countries and over time, we develop a set of empiric observations with which any theory about excess male mortality and its correlates will have to contend. We show that as societies develop, M/F survival first declines and then increases, a "sex difference in mortality transition" embedded within the demographic and epidemiologic transitions. After the onset of this transition, cross-sectional variation in excess male mortality exhibits a consistent pattern of greater female resilience to mortality under socio-economic adversity. The causal mechanisms underlying these associations merit further research.
View details for PubMedID 29349167
- Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis LANCET INFECTIOUS DISEASES 2015; 15 (10): 1203-1210
Leading Causes of Death among Asian American Subgroups (2003-2011)
2015; 10 (4)
Our current understanding of Asian American mortality patterns has been distorted by the historical aggregation of diverse Asian subgroups on death certificates, masking important differences in the leading causes of death across subgroups. In this analysis, we aim to fill an important knowledge gap in Asian American health by reporting leading causes of mortality by disaggregated Asian American subgroups.We examined national mortality records for the six largest Asian subgroups (Asian Indian, Chinese, Filipino, Japanese, Korean, Vietnamese) and non-Hispanic Whites (NHWs) from 2003-2011, and ranked the leading causes of death. We calculated all-cause and cause-specific age-adjusted rates, temporal trends with annual percent changes, and rate ratios by race/ethnicity and sex. Rankings revealed that as an aggregated group, cancer was the leading cause of death for Asian Americans. When disaggregated, there was notable heterogeneity. Among women, cancer was the leading cause of death for every group except Asian Indians. In men, cancer was the leading cause of death among Chinese, Korean, and Vietnamese men, while heart disease was the leading cause of death among Asian Indians, Filipino and Japanese men. The proportion of death due to heart disease for Asian Indian males was nearly double that of cancer (31% vs. 18%). Temporal trends showed increased mortality of cancer and diabetes in Asian Indians and Vietnamese; increased stroke mortality in Asian Indians; increased suicide mortality in Koreans; and increased mortality from Alzheimer's disease for all racial/ethnic groups from 2003-2011. All-cause rate ratios revealed that overall mortality is lower in Asian Americans compared to NHWs.Our findings show heterogeneity in the leading causes of death among Asian American subgroups. Additional research should focus on culturally competent and cost-effective approaches to prevent and treat specific diseases among these growing diverse populations.
View details for DOI 10.1371/journal.pone.0124341
View details for Web of Science ID 000353659100048
View details for PubMedID 25915940
View details for PubMedCentralID PMC4411112
An exploration of China's mortality decline under Mao: A provincial analysis, 1950-80
POPULATION STUDIES-A JOURNAL OF DEMOGRAPHY
2015; 69 (1): 39-56
Between 1950 and 1980, China experienced the most rapid sustained increase in life expectancy of any population in documented global history. We know of no study that has quantitatively assessed the relative importance of the various explanations proposed for this gain in survival. We have created and analysed a new, province-level panel data set spanning the decades between 1950 and 1980 by combining historical information from China's public health archives, official provincial yearbooks, and infant and child mortality records contained in the 1988 National Survey of Fertility and Contraception. Although exploratory, our results suggest that gains in school enrolment and public health campaigns together are associated with 55-70 per cent of China's dramatic reductions in infant and under-5 mortality during our study period. These results underscore the importance of non-medical determinants of population health, and suggest that, in some circumstances, general education of the population may amplify the effectiveness of public health interventions. Supplementary material for this article (Babiarz et al. 2014, Suppl.) is available at: http://dx.doi.org/10.1080/00324728.2014.972432.
View details for DOI 10.1080/00324728.2014.972432
View details for Web of Science ID 000349446200001
View details for PubMedID 25495509
View details for PubMedCentralID PMC4331212
- Disparities in health and health care in Myanmar. Lancet (London, England) 2015; 386 (10008): 2053
Diabetes prevalence and risk factors among vietnamese adults: findings from community-based screening programs.
2015; 38 (5): e77–8
View details for PubMedID 25908162
Cardiovascular Disease Mortality in Asian Americans
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2014; 64 (23): 2486-2494
Asian Americans are a rapidly growing racial/ethnic group in the United States. Our current understanding of Asian-American cardiovascular disease mortality patterns is distorted by the aggregation of distinct subgroups.The purpose of the study was to examine heart disease and stroke mortality rates in Asian-American subgroups to determine racial/ethnic differences in cardiovascular disease mortality within the United States.We examined heart disease and stroke mortality rates for the 6 largest Asian-American subgroups (Asian Indian, Chinese, Filipino, Japanese, Korean, and Vietnamese) from 2003 to 2010. U.S. death records were used to identify race/ethnicity and cause of death by International Classification of Diseases-10th revision coding. Using both U.S. Census data and death record data, standardized mortality ratios (SMRs), relative SMRs (rSMRs), and proportional mortality ratios were calculated for each sex and ethnic group relative to non-Hispanic whites (NHWs).In this study, 10,442,034 death records were examined. Whereas NHW men and women had the highest overall mortality rates, Asian Indian men and women and Filipino men had greater proportionate mortality burden from ischemic heart disease. The proportionate mortality burden of hypertensive heart disease and cerebrovascular disease, especially hemorrhagic stroke, was higher in every Asian-American subgroup compared with NHWs.The heterogeneity in cardiovascular disease mortality patterns among diverse Asian-American subgroups calls attention to the need for more research to help direct more specific treatment and prevention efforts, in particular with hypertension and stroke, to reduce health disparities for this growing population.
View details for DOI 10.1016/j.jacc.2014.08.048
View details for Web of Science ID 000345962400007
View details for PubMedID 25500233
View details for PubMedCentralID PMC4274749
An observational study of socioeconomic and clinical gradients among diabetes patients hospitalized for avoidable causes: evidence of underlying health disparities in China?
INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH
Diabetes is an ambulatory care sensitive condition that can generally be managed in outpatient settings with little or no need for inpatient care. As a preliminary step to investigate whether health disparities can be detected in the inpatient setting in China, we study how diabetic patients hospitalized without prior primary care contact or with greater severity of illness differ from other diabetic inpatients along socioeconomic and clinical dimensions.We conduct an observational study using three years of clinical data for more than 1,800 adult patients with diabetes at two tertiary hospitals in East China. Univariate analysis and probit regression are used to characterize the differences in socioeconomic and clinical factors between patients hospitalized for diabetes with no prior primary care contact and those hospitalized with previous treatment experience. Secondarily, we use ordinary least squares regression to estimate the socioeconomic and clinical differences associated with poor serum glucose control at admission.We find that compared with patients hospitalized after prior treatment experience, inpatients with no previous primary care contact for diabetes have worse clinical laboratory values, are more likely to be young and male, to have lower education attainment, and to have poorer blood sugar control. Insurance, urban residence, and previous use of diabetic medication are in turn negatively correlated with HbA1c levels upon admission.Among hospitalized diabetic patients, socioeconomic factors such as lower education attainment, rural residence and lack of full insurance are associated with avoidable hospitalizations or worse indicators of health. Although we cannot definitively rule out selection bias, these findings are consistent with health disparities observable even at the inpatient level. Future studies should study the underlying mechanism by which traditionally vulnerable groups are more likely to be hospitalized for avoidable causes and with greater severity of illness.
View details for DOI 10.1186/1475-9276-13-9
View details for Web of Science ID 000332938900002
View details for PubMedID 24479633
- Will Demographic Change Slow China's Rise? JOURNAL OF ASIAN STUDIES 2013; 72 (3): 505-518
Contracting with private providers for primary care services: evidence from urban China.
Health economics review
2013; 3 (1): 1-?
Controversy surrounds the role of the private sector in health service delivery, including primary care and population health services. China's recent health reforms call for non-discrimination against private providers and emphasize strengthening primary care, but formal contracting-out initiatives remain few, and the associated empirical evidence is very limited. This paper presents a case study of contracting with private providers for urban primary and preventive health services in Shandong Province, China. The case study draws on three primary sources of data: administrative records; a household survey of over 1600 community residents in Weifang and City Y; and a provider survey of over 1000 staff at community health stations (CHS) in both Weifang and City Y. We supplement the quantitative data with one-on-one, in-depth interviews with key informants, including local officials in charge of public health and government finance.We find significant differences in patient mix: Residents in the communities served by private community health stations are of lower socioeconomic status (more likely to be uninsured and to report poor health), compared to residents in communities served by a government-owned CHS. Analysis of a household survey of 1013 residents shows that they are more willing to do a routine health exam at their neighborhood CHS if they are of low socioeconomic status (as measured either by education or income). Government and private community health stations in Weifang did not statistically differ in their performance on contracted dimensions, after controlling for size and other CHS characteristics. In contrast, the comparison City Y had lower performance and a large gap between public and private providers. We discuss why these patterns arose and what policymakers and residents considered to be the main issues and concerns regarding primary care services.
View details for DOI 10.1186/2191-1991-3-1
View details for PubMedID 23327666
View details for PubMedCentralID PMC3599686
- Risk adjustment and prevention CANADIAN JOURNAL OF ECONOMICS-REVUE CANADIENNE D ECONOMIQUE 2012; 45 (4): 1586-1607
Soil-Transmitted Helminth Infections and Correlated Risk Factors in Preschool and School-Aged Children in Rural Southwest China
2012; 7 (9)
We conducted a survey of 1707 children in 141 impoverished rural areas of Guizhou and Sichuan Provinces in Southwest China. Kato-Katz smear testing of stool samples elucidated the prevalence of ascariasis, trichuriasis and hookworm infections in pre-school and school aged children. Demographic, hygiene, household and anthropometric data were collected to better understand risks for infection in this population. 21.2 percent of pre-school children and 22.9 percent of school aged children were infected with at least one of the three types of STH. In Guizhou, 33.9 percent of pre-school children were infected, as were 40.1 percent of school aged children. In Sichuan, these numbers were 9.7 percent and 6.6 percent, respectively. Number of siblings, maternal education, consumption of uncooked meat, consumption of unboiled water, and livestock ownership all correlated significantly with STH infection. Through decomposition analysis, we determined that these correlates made up 26.7 percent of the difference in STH infection between the two provinces. Multivariate analysis showed that STH infection is associated with significantly lower weight-for-age and height-for-age z-scores; moreover, older children infected with STHs lag further behind on the international growth scales than younger children.
View details for DOI 10.1371/journal.pone.0045939
View details for Web of Science ID 000309517500047
View details for PubMedID 23029330
- The New Demographic Transition: Most Gains in Life Expectancy Now Realized Late in Life JOURNAL OF ECONOMIC PERSPECTIVES 2012; 26 (3): 137-156
- Prescribing institutions: Explaining the evolution of physician dispensing JOURNAL OF INSTITUTIONAL ECONOMICS 2012; 8 (2): 247-270
Socioeconomic Correlates of Inpatient Spending for Patients with Type 2 Diabetes Mellitus in China: Evidence from Hangzhou
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
2012; 120 (1): 35-44
We evaluated the factors associated with inpatient costs including total costs, pharmaceutical costs and laboratory costs for diabetes-related admissions.Using data for 960 adult patients admitted between May 2005 and April 2008 with a primary or secondary diagnosis of type 2 diabetes mellitus (DM) at Sir Run Run Shaw Hospital affiliated with Zhejiang University Medical School (SRRSH) in Hangzhou, China, we evaluate the association between patient characteristics and inpatient costs with multivariable regression analyses.Total inpatient costs were positively associated with age, higher UKPDS stroke risk score, and presence of any complication. A regression that included patient socioeconomic and clinical characteristics explained 21.5% of the variation in total inpatient costs; regression estimates indicate that patients with coronary artery disease, retinopathy, nephropathy, neuropathy, and diabetic foot had inpatient costs that were respectively 93.7%, 14.0%, 17.5%, 11.5% and 89.0% higher than otherwise similar patients without those complications. Pharmaceutical costs did not differ by insurance coverage. Insured patients spent 7-16% more on laboratory tests than otherwise similar patients did.Clinical factors, especially presence of diabetes-related complications, appear to be the primary determinants of variation in inpatient costs for patients with type 2 DM in China. To mitigate the health costs increases associated with China's DM epidemic, policymakers should focus on cost-effective ways to manage patients in outpatient settings to prevent the complications associated with diabetes.
View details for DOI 10.1055/s-0031-1291178
View details for Web of Science ID 000299495600006
View details for PubMedID 22237582
The New Demographic Transition: Most Gains in Life Expectancy Now Realized Late in Life.
The journal of economic perspectives : a journal of the American Economic Association
2012; 26 (3): 137–56
The share of increases in life expectancy realized after age 65 was only about 20 percent at the beginning of the 20th century for the US and 16 other countries at comparable stages of development; but that share was close to 80 percent by the dawn of the 21st century, and is almost certainly approaching 100 percent asymptotically. This new demographic transition portends a diminished survival effect on working life. For high-income countries at the forefront of the longevity transition, expected lifetime labor force participation as a percent of life expectancy is declining. Innovative policies are needed if societies wish to preserve a positive relationship running from increasing longevity to greater prosperity.
View details for PubMedID 25076810
- Demographic Change, Intergeneration al Transfers, and the Challenges to Social Protection Systems in China Aging, Economic Growth, and Old - Age Security in Asia Edward Elgar . 2012
- Health, Education, and China’s Demographic Tra nsition Since 1950 The Chinese Economy : A New Transition International Economics Association, Palgrave-MacMillian . 2012: 150–165
- Children of China's Future YaleGlobal Online 2012
Educational disparities in quality of diabetes care in a universal health insurance system: evidence from the 2005 Korea National Health and Nutrition Examination Survey
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE
2011; 23 (4): 397-404
To investigate educational disparities in the care process and health outcomes among patients with diabetes in the context of South Korea's universal health insurance system.Bivariate and multiple regression analyses of data from a cross-sectional health survey.A nationally representative and population-based survey, the 2005 Korea National Health and Nutrition Examination Survey.Respondents aged 40 or older who self-reported prior diagnosis with diabetes (n= 1418).Seven measures of the care process and health outcomes, namely (i) receiving medical treatment for diabetes, (ii) ever received diabetes education, (iii) received dilated eye examination in the past year, (iv) received microalbuminuria test in the past year, (v) having activity limitation due to diabetes, (vi) poor self-rated health and (vii) self-rated health on a visual analog scale.Except for receiving medical care for diabetes, overall process quality was low, with only 25% having ever received diabetes education, 39% having received a dilated eye examination in the past year and 51% having received a microalbuminuria test in the past year. Lower education level was associated with both poorer care processes and poorer health outcomes, whereas lower income level was only associated with poorer health outcomes.While South Korea's universal health insurance system may have succeeded in substantially reducing financial barriers related to diabetes care, the quality of diabetes care is low overall and varies by education level. System-level quality improvement efforts are required to address the weaknesses of the health system, thereby mitigating educational disparities in diabetes care quality.
View details for DOI 10.1093/intqhc/mzr035
View details for Web of Science ID 000292834300006
View details for PubMedID 21705771
- Quality Adjustment for Health Care Spending on Chronic Disease: Evidence from Diabetes Treatment, 1999-2009 AMERICAN ECONOMIC REVIEW 2011; 101 (3): 206-211
- Soft budget constraints and ownership: Empirical evidence from US hospitals ECONOMICS LETTERS 2011; 110 (1): 7-11
Quality Adjustment for Health Care Spending on Chronic Disease: Evidence from Diabetes Treatment, 1999–2009.
The American economic review
2011; 101 (3): 206–11
US health care expenditures reached $2.5 trillion in 2009, representing 17.6 percent of gross domestic product (GDP) and $8,086 per person (US Department of Health and Human Services Centers for Medicare and Medicaid Services 2011). Since health care represents a large and growing share of the economy, and factors such as population aging imply that chronic disease treatment will continue to expand as a share of health expenditures, developing methods for assessing the value of quality improvement for chronic disease spending is of increasing importance for accurately measuring real economic activity. This paper develops a method for assessing the value of quality changes associated with health care for patients living with one important chronic disease, diabetes mellitus, using 11 years of detailed data on spending and quality of care for over 800 patients. We first provide an overview of measurement issues for health care quality, and then present our data, methods, results, and a brief discussion.
View details for PubMedID 29517880
The Global Challenge of Antimicrobial Resistance: Insights from Economic Analysis
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
2010; 7 (8): 3141-3149
The prevalence of antimicrobial resistance (AR) limits the therapeutic options for treatment of infections, and increases the social benefit from disease prevention. Like an environmental resource, antimicrobials require stewardship. The effectiveness of an antimicrobial agent is a global public good. We argue for greater use of economic analysis as an input to policy discussion about AR, including for understanding the incentives underlying health behaviors that spawn AR, and to supplement other methods of tracing the evolution of AR internationally. We also discuss integrating antimicrobial stewardship into global health governance.
View details for DOI 10.3390/ijerph7083141
View details for Web of Science ID 000281411100011
View details for PubMedID 20948953
View details for PubMedCentralID PMC2954574
Comparing public and private hospitals in China: Evidence from Guangdong
BMC HEALTH SERVICES RESEARCH
The literature comparing private not-for-profit, for-profit, and government providers mostly relies on empirical evidence from high-income and established market economies. Studies from developing and transitional economies remain scarce, especially regarding patient case-mix and quality of care in public and private hospitals, even though countries such as China have expanded a mixed-ownership approach to service delivery. The purpose of this study is to compare the operations and performance of public and private hospitals in Guangdong Province, China, focusing on differences in patient case-mix and quality of care.We analyze survey data collected from 362 government-owned and private hospitals in Guangdong Province in 2005, combining mandatorily reported administrative data with a survey instrument designed for this study. We use univariate and multi-variate regression analyses to compare hospital characteristics and to identify factors associated with simple measures of structural quality and patient outcomes.Compared to private hospitals, government hospitals have a higher average value of total assets, more pieces of expensive medical equipment, more employees, and more physicians (controlling for hospital beds, urban location, insurance network, and university affiliation). Government and for-profit private hospitals do not statistically differ in total staffing, although for-profits have proportionally more support staff and fewer medical professionals. Mortality rates for non-government non-profit and for-profit hospitals do not statistically differ from those of government hospitals of similar size, accreditation level, and patient mix.In combination with other evidence on health service delivery in China, our results suggest that changes in ownership type alone are unlikely to dramatically improve or harm overall quality. System incentives need to be designed to reward desired hospital performance and protect vulnerable patients, regardless of hospital ownership type.
View details for DOI 10.1186/1472-6963-10-76
View details for Web of Science ID 000277049800001
View details for PubMedID 20331886
- PRESCRIBING CULTURES AND PHARMACEUTICAL POLICIES IN THE ASIA-PACIFIC (Book Review) HEALTH AFFAIRS 2010; 29 (2): 329-330
Inpatient treatment of diabetic patients in Asia: evidence from India, China, Thailand and Malaysia
2010; 27 (1): 101-108
The prevalence of Type 2 diabetes mellitus (DM) has grown rapidly, but little is known about the drivers of inpatient spending in low- and middle-income countries. This study aims to compare the clinical presentation and expenditure on hospital admission for inpatients with a primary diagnosis of Type 2 DM in India, China, Thailand and Malaysia.We analysed data on adult, Type 2 DM patients admitted between 2005 and 2008 to five tertiary hospitals in the four countries, reporting expenditures relative to income per capita in 2007.Hospital admission spending for diabetic inpatients with no complications ranged from 11 to 75% of per-capita income. Spending for patients with complications ranged from 6% to over 300% more than spending for patients without complications treated at the same hospital. Glycated haemoglobin was significantly higher for the uninsured patients, compared with insured patients, in India (8.6 vs. 8.1%), Hangzhou, China (9.0 vs. 8.1%), and Shandong, China (10.9 vs. 9.9%). When the hospital admission expenditures of the insured and uninsured patients were statistically different in India and China, the uninsured always spent less than the insured patients.With the rising prevalence of DM, households and health systems in these countries will face greater economic burdens. The returns to investment in preventing diabetic complications appear substantial. Countries with large out-of-pocket financing burdens such as India and China are associated with the widest gaps in resource use between insured and uninsured patients. This probably reflects both overuse by the insured and underuse by the uninsured.
View details for DOI 10.1111/j.1464-5491.2009.02874.x
View details for Web of Science ID 000273451900015
View details for PubMedID 20121896
- "Kan Bing Nan, Kan Bing Gui": Challenges for China’s Healthcare System Thirty Years into Reform Growing Pains: Tensions and Opportunities in China’s Transformation Walter H. Shorenstein Asia - Pacif ic Research Center. 2010
- The Diabetes Epidemic in the Asia - Pacific Aging Asia: Economic and Social Implications of Rapid Demographic Change in China, Japan, and South Korea Walter H. Shorenstein Asia - Pacific Research Center series with Brookings Institution Press. 2010
- Introduction Aging Asia: Economic and Social Implications of Rapid Demographic Change in China, Japan, and South Korea Walter H. Shorenstein Asia - Pacific Research Center series with Brookings Institution Press. 2010
- Aging Asia: The Economic and Social Implications of Rapid Demographic Change in China, Japan, and South Korea Book Brooking Institution Press. 2010
- Jobs and Kids: Female Employment and Fertility in Rural China VoxEU.org 2010
The Net Value of Health Care for Patients With Type 2 Diabetes, 1997 to 2005
ANNALS OF INTERNAL MEDICINE
2009; 151 (6): 386-W127
The net economic value of increased health care spending remains unclear, especially for chronic diseases.To assess the net value of health care for patients with type 2 diabetes.Economic analysis of observational cohort data.Mayo Clinic, Rochester, Minnesota, a not-for-profit integrated health care delivery system.613 patients with type 2 diabetes.Changes in inflation-adjusted annual health care spending and in health status between 1997 and 2005 (with health status defined as 10-year cardiovascular risk), holding age and diabetes duration constant across the observation period ("modifiable risk"), and simulated outcomes for all diabetes complications based on the UKPDS (United Kingdom Perspective Diabetes Study) Outcomes Model. Net value was estimated as the present discounted monetary value of improved survival and avoided treatment spending for coronary heart disease minus the increase in annual spending per patient.Assuming that 1 life-year is worth $200,000 and accounting for changes in modifiable cardiovascular risk, the net value of changes in health care for patients with type 2 diabetes was $10,911 per patient (95% CI, -$8480 to $33,402) between 1997 and 2005, a positive dollar value that suggests the value of health care has improved despite increased spending. A second approach based on diabetes complications yielded a net value of $6931 per patient (CI, -$186,901 to $211,980).The patient population was homogeneous and small, and the wide CIs of the estimates are compatible with a decrease as well as an increase in value.The economic value of improvements in health status for patients with type 2 diabetes seems to exceed or equal increases in health care spending, suggesting that those increases were worth the extra cost. However, the possibility that society is getting less value for its money could not be statistically excluded, and there is opportunity to improve the value of diabetes-related health care.None.
View details for Web of Science ID 000270390100003
View details for PubMedID 19755364
- Human Resource Management Technology Diffusion through Global Supply Chains: Buyer-directed Factory-based Health Care in India WORLD DEVELOPMENT 2009; 37 (9): 1484-1493
- Provider payment incentives: international comparisons INTERNATIONAL JOURNAL OF HEALTH CARE FINANCE & ECONOMICS 2009; 9 (2): 113-115
The effect of soft budget constraints on access and quality in hospital care
INTERNATIONAL JOURNAL OF HEALTH CARE FINANCE & ECONOMICS
2009; 9 (2): 211-232
Given an increasingly complex web of financial pressures on providers, studies have examined how hospitals' overall financial health affects different aspects of hospital operations. In our study, we develop an empirical proxy for the concept of soft budget constraint (SBC, Kornai, Kyklos 39:3-30, 1986) as an alternative financial measure of a hospital's overall financial health and offer an initial estimate of the effect of SBCs on hospital access and quality. An organization has a SBC if it can expect to be bailed out rather than shut down. Our conceptual model predicts that hospitals facing softer budget constraints will be associated with less aggressive cost control, and their quality may be better or worse, depending on the scope for damage to quality from noncontractible aspects of cost control. We find that hospitals with softer budget constraints are less likely to shut down safety net services. In addition, hospitals with softer budget constraints appear to have better mortality outcomes for elderly heart attack patients.
View details for DOI 10.1007/s10754-009-9066-2
View details for Web of Science ID 000265963900008
View details for PubMedID 19408114
Soft budget constraints in China: Evidence from the Guangdong hospital industry
INTERNATIONAL JOURNAL OF HEALTH CARE FINANCE & ECONOMICS
2009; 9 (2): 233-242
Using data from 276 general acute hospitals in the Pearl River Delta region of Guangdong Province from 2002 and 2004, we construct a preliminary metric of budget constraint softness. We find that, controlling for hospital size, ownership, and other factors, a Chinese hospital's probability of receiving government financial support is inversely associated with the hospital's previous net revenue, an association consistent with soft budget constraints.
View details for DOI 10.1007/s10754-009-9067-1
View details for Web of Science ID 000265963900009
View details for PubMedID 19399608
- Measuring Selection Incentives in Managed Care: Evidence From the Massachusetts State Employee Insurance Program JOURNAL OF RISK AND INSURANCE 2009; 76 (1): 159-175
- Introduction Prescribing Cultures and Pharmaceutical Policy in the Asia - Pacific Walter H. Shorenstein Asia - Pacific Research Center series with Brookings Institution Press. 2009
- Physician s and pharmacists in comparative historical perspective: The ca se of South Korea Prescribing Cultures and Pharmaceutical Policy in the Asia Pacific Shorenstein Asia - Pacific Research Center series with Brookings Institution Press. 2009 : 267–280
HOSPITAL OWNERSHIP AND QUALITY OF CARE: WHAT EXPLAIN'S THE DIFFERENT RESULTS IN THE LITERATURE?
2008; 17 (12): 1345-1362
This systematic review examines what factors explain the diversity of findings regarding hospital ownership and quality. We identified 31 observational studies written in English since 1990 that used multivariate analysis to examine quality of care at nonfederal general acute, short-stay US hospitals. We find that pooled estimates of ownership effects are sensitive to the subset of studies included and the extent of overlap among hospitals analyzed in the underlying studies. Ownership does appear to be systematically related to differences in quality among hospitals in several contexts. Whether studies find for-profit and government-controlled hospitals to have higher mortality rates or rates of adverse events than their nonprofit counterparts depends on data sources, time period, and region covered. Policymakers should be aware of the underlying reasons for conflicting evidence in this literature, and the strengths and weaknesses of meta-analytic synthesis. The 'true' effect of ownership appears to depend on institutional context, including differences across regions, markets, and over time.
View details for DOI 10.1002/hec.1333
View details for Web of Science ID 000261635300003
View details for PubMedID 18186547
- Soft budget constraints and the property rights theory of ownership ECONOMICS LETTERS 2008; 100 (3): 425-427
Pharmaceutical policy in China
2008; 27 (4): 1042-1050
Contradictory goals plague China's pharmaceutical policy. The government wants to develop the domestic pharmaceutical industry and has used drug pricing to cross-subsidize public hospitals. Yet the government also aims to control drug spending through price caps and profit-margin regulations to guarantee access even for poor patients. The resulting system has distorted market incentives, increased consumers' costs, and financially rewarded inappropriate prescribing, thus undermining public health. Pharmaceuticals account for about half of total health spending in China, representing 43 percent of spending per inpatient episode and 51 percent of spending per outpatient visit. Yet some essential medicines are unavailable or of questionable quality.
View details for DOI 10.1377/hlthaff.27.4.1042
View details for Web of Science ID 000257635900018
View details for PubMedID 18607039
- Emerging health economics and outcomes research in the Asia-Pacific region VALUE IN HEALTH 2008; 11: S1-S2
Health service delivery in China: A literature review
2008; 17 (2): 149-165
We report the results of a review of the Chinese- and English-language literatures on service delivery in China, asking how well China's health-care providers perform and what determines their performance. Although data and methodological limitations suggest caution in drawing conclusions, a critical reading of the available evidence suggests that current health service delivery in China leaves room for improvement, in terms of quality, responsiveness to patients, efficiency, cost escalation, and equity. The literature suggests that these problems will not be solved by simply shifting ownership to the private sector or by simply encouraging providers -- public and private -- to compete with one another for individual patients. By contrast, substantial improvements could be (and in some places have already been) made by changing the way providers are paid -- shifting away from fee-for-service and the distorted price schedule. Other elements of 'active purchasing' by insurers could further improve outcomes. Rigorous evaluations, based on richer micro-level data, could considerably strengthen the evidence base for service delivery policy in China.
View details for DOI 10.1002/hec.1306
View details for Web of Science ID 000253239400001
View details for PubMedID 17880024
- Developing Commercial Health Insurance in China Field Note in Perspectives: China and the World 2008; 10 (3): 141-155
- From Plan to Market in the Health Sector? China's Experience Journal of Asian Economics 2008; 19: 400-412
- Healthcare Reforms in Central and Eastern Europe: Overview and Possible Implications of China Bijao (Comparative Studies) 2007; 32: 119-132
Physician dual practice
2006; 78 (2-3): 157-166
Physicians employed in government clinics and hospitals also frequently have private practices. The economic theory of such dual practice is relatively limited and recent. We provide a summary and comparison of five models of dual practice, including one we have developed based on total compensation theory and contracting limitations. We also discuss whether theoretical predictions are consistent with empirical evidence from developed and developing countries. We argue that the social trade-off between the benefits and costs of dual practice hinge on the quality of a country's contracting institutions. The conclusion outlines a proposed research agenda for better understanding this widespread phenomenon in the health sector and in other segments of society.
View details for DOI 10.1016/j.healthpol.2005.09.007
View details for Web of Science ID 000240837500005
View details for PubMedID 16253383
Provider choice of quality and surplus.
International journal of health care finance & economics
2006; 6 (2): 103-117
We study the quality choices of institutional health-care providers, such as hospitals, assuming that the utility function of the key organizational decision maker includes both quality of care and financial surplus. We are primarily concerned with how changes in outside claims--particularly proportional outside claims--on the provider's financial surplus affect his choice of quality. We use the term "rate of surplus retention" to refer to the fraction of surplus remaining after deducting all such claims. Using the Arrow-Pratt coefficient of relative risk aversion as a measure of curvature of the provider's utility-from-money function, we show that increasing the surplus retention rate increases (decreases) quality if the provider's coefficient of relative risk aversion is greater than (less than) 1.
View details for PubMedID 16783504
- Ownership and performance of health service organizations: Evidence from hospitals Global Forum Update on Research for Health 2006; 3: 142-145
- Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States GLOBALIZATION AND HEALTH 2006; 2
Multitasking and mixed systems for provider payment
JOURNAL OF HEALTH ECONOMICS
2005; 24 (1): 211-223
The problem of multitasking refers to the challenge of designing incentives to motivate appropriate effort across multiple tasks when the desired outcomes for some tasks are more difficult to measure than others. Multitasking is pervasive in health care. I use a simple model to show that the problem of multitasking further strengthens conventional arguments for mixed payment systems such as partial capitation. When pay-for-performance metrics are imperfect for rewarding service-specific quality efforts, using mixed payment helps to balance incentives for quality effort across services.
View details for DOI 10.1016/j.jhealeco.2004.09.001
View details for Web of Science ID 000226272400010
View details for PubMedID 15617795
Hospital competition under regulated prices: application to urban health sector reforms in China.
International journal of health care finance & economics
2004; 4 (4): 343-368
We develop a model of public-private hospital competition under regulated prices, recognizing that hospitals are multi-service firms and that equilibria depend on the interactions of patients, hospital administrators, and physicians. We then use data from China to calibrate a simulation model of the impact of China's recent payment and organizational reforms on cost, quality and access. Both the analytic and simulation results show how providing implicit insurance through distorted prices leads to over/under use of services by profitability, which in turn fuels cost escalation and reduces access for those who cannot afford to self-pay for care. Simulations reveal the benefits of mixed payment and expanded insurance cover for mitigating these distortions.
View details for PubMedID 15467409
Addressing government and market failures with payment incentives: Hospital reimbursement reform in Hainan, China
SOCIAL SCIENCE & MEDICINE
2004; 58 (2): 267-277
This paper examines the role of provider payment policy as an instrument for addressing government and market failures and controlling costs in the health sector, particularly in developing countries. We empirically evaluate the impact of provider payment reform in Hainan province, China, on expenditures for different categories of services that had been subject to distorted prices under fee-for-service. Using a pre-post study design with a control group, we analyze two years of claims data to assess the impact of a January 1997 change to prospective payment for a sub-sample of the hospitals. This difference-in-difference empirical strategy allows us to isolate the supply-side payment reform effects from demand-side policy interventions. We find that prepayment is associated with a slower increase in spending on expensive drugs and high technology services, compared to fee-for-service. The fact that payment reform is associated with reduced growth in spending on the most expensive drugs is particularly encouraging, given that drugs account for a remarkably high percentage of both the level and growth of aggregate health expenditure in China. Payment reform can be an effective policy instrument for correcting market failures and adverse side effects of government health sector interventions (such as distorted prices to assure access to basic services), both of which can lead to excessive health care expenditure growth. Such health spending growth can have a particularly high opportunity cost for developing countries.
View details for DOI 10.1016/S0277-9536(03)00010-8
View details for Web of Science ID 000187743100006
View details for PubMedID 14604613
Healthcare payment incentives: a comparative analysis of reforms in Taiwan, South Korea and China.
Applied health economics and health policy
2004; 3 (1): 47-56
Payment incentives to both consumers and providers have significant consequences for the equity and efficiency of a healthcare system, and have recently come to the fore in health policy reforms. This review first discusses the economic rationale for the apparent international convergence toward payment systems with mixed demand- and supply-side cost sharing. The recent payment reforms undertaken in Taiwan, South Korea and China are then summarised. Available evidence clearly indicates that payment incentives matter, and, in particular, that supply-side cost sharing can improve efficiency without undermining equity. Further study and monitoring of health service quality and risk selection is warranted.
View details for PubMedID 15702940
- Zhuangui Zhong De Fuli, Xuanze He Yizhixing (Welfare, Choice and Solidarity in Transition -- Chinese edition) CITIC Publishing House. 2003
Provider payment reform in China: The case of hospital reimbursement in Hainan Province
2001; 10 (4): 325-339
This paper develops a simple model of payment incentives and empirically evaluates provider payment reform in Hainan Province, China. We use a pre-post study design with a control group to analyse two years of claims data to assess the impact of a January 1997 change to prospective payment for a sub-sample of the hospitals. This difference-in-difference empirical strategy allows us to isolate the supply-side payment reform effects from demand-side changes, in contrast with previous studies of China's reforms. Our results validate the theory that Chinese providers' behavioural response to payment incentives is similar to that reported in the literature derived from the experience of industrialized countries. We find that prepayment is associated with a slower rate of growth of overall expenditures, programme spending and patient co-payments per inpatient admission, compared to fee-for-service (FFS). These findings suggest cautious optimism regarding the effectiveness of prospective payment for controlling costs and should be encouraging for policymakers in developing and transitional economies considering replacement of FFS with more aggregated forms of provider payment.
View details for Web of Science ID 000169548000006
View details for PubMedID 11400255
- Welfare, Choice and Solidarity in Transition: Reforming the Health Sector in Eastern Europe Cambridge University Press. 2001
The design and interpretation of contracts: Why complexity matters
NORTHWESTERN UNIVERSITY LAW REVIEW
2000; 95 (1): 91-132
View details for Web of Science ID 000165397100002